Surrogate end points in heart failure trials

被引：17

作者：

Gheorghiade, M

Adams, KF

Gattis, WA

Teerlink, JR

Orlandi, C

O'Connor, CM

机构：

[1] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA

[2] Univ N Carolina, Chapel Hill, NC USA

[3] Duke Clin Res Inst, Durham, NC USA

[4] Univ Calif San Francisco, Sch Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA

[5] Otsuka Maryland Res Inst, Rockville, MD USA

来源：

AMERICAN HEART JOURNAL | 2003年 / 145卷 / 02期

关键词：

D O I：

10.1067/mhj.2003.159

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S67 / S70

页数：4

共 22 条

[1] Surrogate end points in heart failure [J].

Anand, IS ;

Florea, VG ;

Fisher, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1414-1421

[2] A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) [J].

Califf, RM ;

Adams, KF ;

McKenna, WJ ;

Gheorghiade, M ;

Uretsky, BF ;

McNulty, SE ;

Darius, H ;

Schulman, K ;

Zannad, F ;

HandbergThurmond, E ;

Harrell, FE ;

Wheeler, W ;

SolerSoler, J ;

Swedberg, K .

AMERICAN HEART JOURNAL, 1997, 134 (01) :44-54

[3] Heart failure 99 - the Moxcon story [J].

Coats, AJS .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 71 (02) :109-111

[4] EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY [J].

COHN, JN ;

ARCHIBALD, DG ;

ZIESCHE, S ;

FRANCIOSA, JA ;

HARSTON, WE ;

TRISTANI, FE ;

DUNKMAN, WB ;

JACOBS, W ;

FRANCIS, GS ;

FLOHR, KH ;

GOLDMAN, S ;

COBB, FR ;

SHAH, PM ;

SAUNDERS, R ;

FLETCHER, RD ;

LOEB, HS ;

HUGHES, VC ;

BAKER, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) :1547-1552

[5] A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].

COHN, JN ;

JOHNSON, G ;

ZIESCHE, S ;

COBB, F ;

FRANCIS, G ;

TRISTANI, F ;

SMITH, R ;

DUNKMAN, WB ;

LOEB, H ;

WONG, ML ;

BHAT, G ;

GOLDMAN, S ;

FLETCHER, RD ;

DOHERTY, J ;

HUGHES, CV ;

CARSON, P ;

CINTRON, G ;

SHABETAI, R ;

HAAKENSON, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310

[6] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].

ECHT, DS ;

LIEBSON, PR ;

MITCHELL, LB ;

PETERS, RW ;

OBIASMANNO, D ;

BARKER, AH ;

ARENSBERG, D ;

BAKER, A ;

FRIEDMAN, L ;

GREENE, HL ;

HUTHER, ML ;

RICHARDSON, DW .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788

[7]

Eichhorn E, 2001, NEW ENGL J MED, V344, P1659

[8] EFFECTS OF VESNARINONE ON MORBIDITY AND MORTALITY IN PATIENTS WITH HEART-FAILURE [J].

FELDMAN, AM ;

BRISTOW, MR ;

PARMLEY, WW ;

CARSON, PE ;

PEPINE, CJ ;

GILBERT, EM ;

STROBECK, JE ;

HENDRIX, GH ;

POWERS, ER ;

BAIN, RP ;

WHITE, BG .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :149-155

[9] Surrogate end points in clinical trials: Are we being misled? [J].

Fleming, TR ;

DeMets, DL .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613

[10]

Hjalmarson Å, 1999, LANCET, V353, P2001

← 1 2 3 →